Citi initiates coverage on Eli Lilly (NYSE: LLY) with a Neutral. Price target $52.

Citi analyst says,"FDA action ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE